Sterling Pharma Solutions

Sterling Pharma Solutions acquires ADC Bio

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Sterling Pharma Solutions, regarding the acquisition of ADC Bio.  Global Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services… read more

Sterling Pharma Solutions acquires API facility in US

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Sterling Pharma Solutions, regarding the acquisition of Alcami’s Germantown, Wisconsin facility in the US. Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s… read more

Sterling Pharma Solutions commences the production of potential COVID-19 treatment

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Sterling Pharma Solutions, regarding the commencement of the production of potential COVID-19 treatment. Global Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently… read more

Subscribe to our email alerts

Email updates